Chellamani Harini, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 19 | 2024 | 296 | 7.520 |
Why?
|
Spasm | 10 | 2024 | 131 | 1.550 |
Why?
|
Epilepsy | 12 | 2023 | 3267 | 1.530 |
Why?
|
Vigabatrin | 8 | 2023 | 88 | 1.460 |
Why?
|
Adrenocorticotropic Hormone | 6 | 2023 | 618 | 1.280 |
Why?
|
Anticonvulsants | 13 | 2023 | 1879 | 1.020 |
Why?
|
Seizures | 11 | 2024 | 2917 | 0.990 |
Why?
|
Prednisolone | 3 | 2023 | 327 | 0.770 |
Why?
|
Electroencephalography | 16 | 2024 | 6189 | 0.750 |
Why?
|
Syndrome | 5 | 2024 | 3280 | 0.600 |
Why?
|
Hormones | 1 | 2021 | 867 | 0.550 |
Why?
|
Corpus Callosum | 2 | 2023 | 749 | 0.500 |
Why?
|
Infant | 23 | 2024 | 36053 | 0.480 |
Why?
|
Seizures, Febrile | 1 | 2015 | 108 | 0.470 |
Why?
|
Epilepsies, Partial | 3 | 2023 | 430 | 0.470 |
Why?
|
Glucocorticoids | 1 | 2021 | 2145 | 0.380 |
Why?
|
Down Syndrome | 1 | 2019 | 892 | 0.360 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1784 | 0.350 |
Why?
|
Retrospective Studies | 18 | 2024 | 80345 | 0.320 |
Why?
|
Patient Readmission | 1 | 2023 | 3322 | 0.310 |
Why?
|
Preoperative Care | 2 | 2018 | 2255 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36286 | 0.310 |
Why?
|
Hippocampus | 1 | 2021 | 3738 | 0.300 |
Why?
|
Child | 21 | 2024 | 79799 | 0.240 |
Why?
|
Biogenic Amines | 1 | 2024 | 53 | 0.240 |
Why?
|
Child, Preschool | 13 | 2024 | 42056 | 0.230 |
Why?
|
Preoperative Period | 2 | 2018 | 555 | 0.220 |
Why?
|
Brain | 4 | 2023 | 26951 | 0.220 |
Why?
|
Movement Disorders | 2 | 2024 | 459 | 0.200 |
Why?
|
Hemispherectomy | 1 | 2022 | 40 | 0.200 |
Why?
|
Humans | 41 | 2024 | 760613 | 0.180 |
Why?
|
Mosaicism | 1 | 2023 | 466 | 0.180 |
Why?
|
Feedback | 1 | 2024 | 791 | 0.170 |
Why?
|
Treatment Outcome | 12 | 2023 | 64981 | 0.170 |
Why?
|
Epilepsy, Generalized | 2 | 2019 | 178 | 0.170 |
Why?
|
Male | 24 | 2024 | 359718 | 0.160 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2019 | 89 | 0.150 |
Why?
|
Female | 23 | 2024 | 391246 | 0.140 |
Why?
|
Hospital Units | 1 | 2018 | 142 | 0.140 |
Why?
|
Dopamine | 1 | 2024 | 1595 | 0.140 |
Why?
|
Age of Onset | 1 | 2024 | 3302 | 0.140 |
Why?
|
Standard of Care | 1 | 2020 | 552 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 172 | 0.130 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2414 | 0.120 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 353 | 0.120 |
Why?
|
Single-Blind Method | 1 | 2018 | 1578 | 0.120 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39262 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 603 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1607 | 0.110 |
Why?
|
Receptors, GABA-A | 1 | 2017 | 621 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2024 | 2567 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.100 |
Why?
|
Status Epilepticus | 1 | 2018 | 456 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 982 | 0.100 |
Why?
|
Head | 1 | 2017 | 922 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 54306 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2001 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10826 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8623 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2013 | 916 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1415 | 0.080 |
Why?
|
Boston | 2 | 2021 | 9278 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 41337 | 0.080 |
Why?
|
Triazoles | 1 | 2014 | 904 | 0.080 |
Why?
|
Genetic Testing | 1 | 2022 | 3531 | 0.080 |
Why?
|
Electrodes, Implanted | 1 | 2013 | 833 | 0.080 |
Why?
|
Adolescent | 9 | 2018 | 87809 | 0.080 |
Why?
|
Epilepsia Partialis Continua | 1 | 2008 | 18 | 0.080 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2011 | 387 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5508 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2014 | 1131 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2017 | 1459 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1007 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12102 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6476 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2011 | 1688 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2688 | 0.060 |
Why?
|
Genetic Variation | 1 | 2019 | 6552 | 0.060 |
Why?
|
Infant, Premature | 1 | 2013 | 2092 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12968 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2056 | 0.050 |
Why?
|
Cosyntropin | 1 | 2022 | 34 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2023 | 26179 | 0.050 |
Why?
|
Mouth Mucosa | 1 | 2023 | 426 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2024 | 663 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2022 | 549 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20080 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2852 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 74333 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14661 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15286 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15840 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15686 | 0.040 |
Why?
|
Ceftriaxone | 1 | 2019 | 176 | 0.040 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2008 | 1469 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 203 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10789 | 0.040 |
Why?
|
Speech Disorders | 1 | 2017 | 180 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 8985 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1229 | 0.030 |
Why?
|
Muscle Hypotonia | 1 | 2017 | 160 | 0.030 |
Why?
|
United States | 1 | 2023 | 72448 | 0.030 |
Why?
|
Zambia | 1 | 2016 | 257 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29661 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1869 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 24102 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 935 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1832 | 0.030 |
Why?
|
Tuberous Sclerosis | 1 | 2020 | 1030 | 0.030 |
Why?
|
Neurology | 1 | 2020 | 779 | 0.030 |
Why?
|
Tanzania | 1 | 2016 | 1383 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 844 | 0.020 |
Why?
|
Sclerosis | 1 | 2011 | 210 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 650 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1013 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20509 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4263 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2514 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4578 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13451 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6964 | 0.020 |
Why?
|
Evoked Potentials, Motor | 1 | 2008 | 461 | 0.020 |
Why?
|
Encephalitis | 1 | 2008 | 437 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6498 | 0.010 |
Why?
|
Caregivers | 1 | 2016 | 2224 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25941 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2008 | 1735 | 0.010 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8556 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40139 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16548 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29957 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 58748 | 0.000 |
Why?
|
Adult | 1 | 2014 | 220007 | 0.000 |
Why?
|